How can an integrated operations and business planning framework increase the productivity of an organization's R&D.
How can pharmaceutical and life sciences companies comply with the increasing demands of government price reporting.
Our deep technology and data management experience will help you better leverage existing information to solve your state reporting and other compliance related challenges from disparate and vast data sources.
How can pharmaceutical and life sciences companies effectively implement proactive pharmacovigilance and drug safety programs
How can pharmaceutical and life sciences companies effectively meet the challenges of negotiating and implementing a corporate integrity agreement
How can pharmaceutical and life sciences companies improve monitoring techniques to anticipate and mitigate compliance risk.
How can pharmaceutical and life sciences companies optimize the internal audit function in a rapidly changing risk environment.
In an atmosphere of declining research and development (R&D) productivity, mounting pricing pressure and changing regulatory requirements, global pharmaceutical and life sciences companies face increasing challenges to achieve and maintain profitable growth. Global pharmaceutical outsourcing offers companies an opportunity to face these challenges. By forming strategic relationships with outsourcing partners, companies can focus on core competencies, access specialised expertise, achieve cost-saving benefits and reduce burn rates that lead directly to greater shareholder value.
How can pharmaceutical and life sciences companies sustain compliance with good clinical practice requirements.
PricewaterhouseCoopers's experienced professionals have thorough knowledge of sales and marketing operations and can recommend the most effective practices to mitigate compliance risk. Our in-depth knowledge in compliance risk analysis enables us to rapidly and effectively facilitate a compliance assessment of the major sales and marketing activities used to promote products.
How to improve efficiency, reduce cost and better manage changes in the Pharma sector
The pharmaceutical industry constantly faces pressure to develop new products and bring them to market. The high cost of R&D, as well as market demand, makes it crucial for the players in the industry to form strategic alliances, often through licensing, co-promotion and co-development agreements.
Process Analytical Technologies (PAT) and Quality by Design (QbD).
Are you unlocking the value of your supply chain?
Building or scaling a business is full of challenges. From obtaining the required funding, attracting and retaining the right skills, to building relationships with key partners.
PwC has developed sophisticated data analysis and testing approaches to help manufacturers close some of the gaps.